JOHN VARGHESE has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are Xeniopro GmbH, METABIO JOULLIE SA and IKEDA MOHANDO CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Special acyclic compounds | |
#6 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | John Varghese | 13 |
#2 | Tucker John | 6 |
#3 | Maillard Michel | 5 |
#4 | Tung Jay S | 5 |
#5 | Hom Roy | 4 |
#6 | Aquino Jose | 4 |
#7 | Brogley Louis | 3 |
#8 | Bredesen Dale E | 3 |
#9 | Probst Gary | 3 |
#10 | Shah Neerav | 3 |
Publication | Filing date | Title |
---|---|---|
US2012071468A1 | Methods of treating mild cognitive impairment (MCI) and related disorders | |
US2008154331A1 | Device for multicentric brain modulation, repair and interface | |
US2005239790A1 | Substituted hydroxyethylamine aspartyl protease inhibitors | |
US2006014737A1 | Methods of treatment of amyloidosis using bi-aryl aspartyl protease inhibitors |